Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +0.88% rallied 2.23% to $162.94 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +1.46% rising 1.17% to 4,591.67 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +1.09% rising 1.87% to 35,227.03. This was the stock's second consecutive day of gains. Johnson & Johnson closed $16.98 below its 52-week high ($179.92), which the company achieved on August 20th.
The stock outperformed some of its competitors Monday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/delayed RHHVF +0.76% fell 0.28% to $395.13, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +1.24% rose 0.11% to $73.42, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE +1.40% fell 5.14% to $51.48. Trading volume (9.0 M) eclipsed its 50-day average volume of 7.1 M.